GlassScriptPhysician profile
Thomas B Shelton
NPI 1710945522
$8,957.25
in general payments reported to CMS, 2019-2025
46 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $1,112 · 2021: $1,024 · 2022: $1,506 · 2023: $1,735 · 2024: $2,309 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,843 · Travel and Lodging: $563 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,843.14 |
| Travel and Lodging | $562.97 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,112.85 | 2019-2024 | Myrbetriq, Xtandi |
| Teleflex LLC | $920.64 | 2024 | |
| Urogen Pharma, INC. | $691.82 | 2021-2024 | |
| Myriad Genetic Laboratories, INC. | $593.87 | 2021-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $570.86 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $527.07 | 2021-2025 | General - Erectile Dysfunction |
| Abbvie INC. | $508.65 | 2020-2025 | Lupron Depot, Botox |
| Janssen Biotech, INC. | $409.43 | 2019-2024 | Erleada, Balversa, Akeega |
| Pfizer INC. | $263.08 | 2019-2024 | |
| Amgen INC. | $262.79 | 2020-2023 | Prolia |
| Novartis Pharmaceuticals Corporation | $251.49 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $228.93 | 2019-2023 | Provenge |
| Myovant Sciences INC. | $218.48 | 2022 | |
| Sun Pharmaceutical Industries INC. | $186.75 | 2023-2025 | Yonsa |
| Merck Sharp & Dohme LLC | $186.34 | 2021-2023 | Keytruda |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Shelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.